185 related articles for article (PubMed ID: 15844973)
1. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
[TBL] [Abstract][Full Text] [Related]
2. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
3. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
Dziadek S; Kunz H
Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer.
Chuang HY; Ren CT; Chao CA; Wu CY; Shivatare SS; Cheng TJ; Wu CY; Wong CH
J Am Chem Soc; 2013 Jul; 135(30):11140-50. PubMed ID: 23819648
[TBL] [Abstract][Full Text] [Related]
6. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
8. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
[TBL] [Abstract][Full Text] [Related]
9. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
10. Automated solid-phase synthesis of protected tumor-associated antigen and blood group determinant oligosaccharides.
Routenberg Love K; Seeberger PH
Angew Chem Int Ed Engl; 2004 Feb; 43(5):602-5. PubMed ID: 14743415
[No Abstract] [Full Text] [Related]
11. Total synthesis of the potential anticancer vaccine KH-1 adenocarcinoma antigen.
Deshpande PP; Danishefsky SJ
Nature; 1997 May; 387(6629):164-6. PubMed ID: 9144285
[TBL] [Abstract][Full Text] [Related]
12. A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
Dziadek S; Hobel A; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2005 Nov; 44(46):7630-5. PubMed ID: 16247815
[No Abstract] [Full Text] [Related]
13. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
Buskas T; Ingale S; Boons GJ
Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
[No Abstract] [Full Text] [Related]
14. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.
Ragupathi G; Coltart DM; Williams LJ; Koide F; Kagan E; Allen J; Harris C; Glunz PW; Livingston PO; Danishefsky SJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13699-704. PubMed ID: 12359877
[TBL] [Abstract][Full Text] [Related]
15. Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.
Kudryashov V; Glunz PW; Williams LJ; Hintermann S; Danishefsky SJ; Lloyd KO
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3264-9. PubMed ID: 11248067
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of oligosaccharides on soluble high-molecular-weight branched polymers in combination with purification by nanofiltration.
Majumdar D; Zhu T; Boons GJ
Org Lett; 2003 Oct; 5(20):3591-4. PubMed ID: 14507180
[TBL] [Abstract][Full Text] [Related]
18. Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.
Geraci C; Consoli GM; Galante E; Bousquet E; Pappalardo M; Spadaro A
Bioconjug Chem; 2008 Mar; 19(3):751-8. PubMed ID: 18293897
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for cancer: synthetic carbohydrate-based vaccines.
Buskas T; Thompson P; Boons GJ
Chem Commun (Camb); 2009 Sep; (36):5335-49. PubMed ID: 19724783
[TBL] [Abstract][Full Text] [Related]
20. Synthetic glycopeptides for the development of cancer vaccines.
Liakatos A; Kunz H
Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
